Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

References

• Abramovitch R, Dafni H, Smouha E, Benjamin L E, Neeman M. In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice. Cancer Research 1999; 59: 5012–5016
   PubMed Web of Science ®Google Scholar
• Aebersold D M, Burri P, Beer K T, Laissue J, Djonov V, Greiner R H, Semenza G L. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Research 2001; 61: 2911–2916
   PubMed Web of Science ®Google Scholar
• Aime S, Botta M, Gianolio E, Terreno E. A p(O(2))-responsive MRI contrast agent based on the redox switch of Manganese(II/III)-Porphyrin complexes. Angewandte Chemie (International Ed. in English) 2000; 39: 747–750
   PubMedGoogle Scholar
• Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I, West C. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clinical Cancer Research 2001; 7: 928–934
   PubMed Web of Science ®Google Scholar
• Al Hallaq H A, Fan X, Zamora M, River J N, Moulder J E, Karczmar G S. Spectrally inhomogeneous BOLD contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR in Biomedicine 2002; 15: 28–36
   PubMedGoogle Scholar
• Al Hallaq H A, River J N, Zamora M, Oikawa H, Karczmar G S. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. International Journal of Radiation Oncology, Biology, Physics 1998; 41: 151–159
   PubMedGoogle Scholar
• Al Sobhi S, Ashari L H, Ingemansson S. Detection of metastatic parathyroid carcinoma with Tc-99m sestamibi imaging. Clinical Nuclear.Medicine 1999; 24: 21–23
   PubMedGoogle Scholar
• Anderson R F, Shinde S S, Hay M P, Gamage S A, Denny W A. Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction. Journal of the American Chemical Society 2003; 125: 748–756
   PubMed Web of Science ®Google Scholar
• Aquino-Parsons C, Luo C, Vikse C M, Olive P L. Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia. Radiotherapy and Oncology 1999; 51: 179–185
   PubMedGoogle Scholar
• Arbeit J M. Quiescent hypervascularity mediated by gain of HIF-1 alpha function. Cold Spring Harbor Symposia on Quantitative Biology 2002; 67: 133–142
   PubMedGoogle Scholar
• Ardenkjaer-Larsen J H, Fridlund B, Gram A, Hansson G, Hansson L, Lerche M H, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proceedings of the National Academy of Sciences of the United States of America 2003; 100: 10158–10163
   PubMed Web of Science ®Google Scholar
• Atkin G, Taylor N J, Daley F M, Stirling J J, Richman P, Glynne-Jones R, d'Arcy J A, Collins D C, Padhani A R. Dynamic contrast-enhanced MRI (DCE-MRI) is a poor biomarker of rectal cancer angiogenesis. British Journal of Surgery 2006; 93(8)992–1000, May
   PubMedGoogle Scholar
• Ballinger J R, Kee J W, Rauth A M. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia. Journal of Nuclear Medicine 1996; 37: 1023–1031
   PubMed Web of Science ®Google Scholar
• Barnhart A J, Voorhees W D, Green M A. Correlation of Cu(PTSM) localization with regional blood flow in the heart and kidney. International Journal of Radiation Applications and Instrumentation Part B 1989; 16: 747–748
   PubMedGoogle Scholar
• Barthel H, Wilson H, Collingridge D R, Brown G, Osman S, Luthra S K, Brady F, Workman P, Price P M, Aboagye E O. In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography. British Journal of Cancer 2004; 90: 2232–2242
   PubMed Web of Science ®Google Scholar
• Baudelet C, Gallez B. How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors?. Magnetic Resonance in Medicine 2002; 48: 980–986
   PubMed Web of Science ®Google Scholar
• Bayes M, Rabasseda X, Prous J R. Gateways to clinical trials. Methods and Findings in Experimental and Clinical Pharmacology 2004; 26: 211–244
   PubMedGoogle Scholar
• Beasley N J, Leek R, Alam M, Turley H, Cox G J, Gatter K, Millard P, Fuggle S, Harris A L. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Research 2002; 62: 2493–2497
   PubMed Web of Science ®Google Scholar
• Beppu T, Kamada K, Yoshida Y, Arai H, Ogasawara K, Ogawa A. Change of oxygen pressure in glioblastoma tissue under various conditions. Journal of Neurooncology 2002; 58: 47–52
   PubMed Web of Science ®Google Scholar
• Bergers G, Benjamin L E. Tumorigenesis and the angiogenic switch. Nature Reviews Cancer 2003; 3: 401–410
   PubMed Web of Science ®Google Scholar
• Bhujwalla Z M, Artemov D, Ballesteros P, Cerdan S, Gillies R J, Solaiyappan M. Combined vascular and extracellular pH imaging of solid tumors. NMR in Biomedicine 2002; 15: 114–119
   PubMed Web of Science ®Google Scholar
• Bhujwalla Z M, Artemov D, Natarajan K, Ackerstaff E, Solaiyappan M. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 2001; 3: 143–153
   PubMed Web of Science ®Google Scholar
• Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clinical Cancer Research 2001; 7: 1661–1668
   PubMed Web of Science ®Google Scholar
• Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Research 2000; 60: 4693–4696
   PubMed Web of Science ®Google Scholar
• Blakey D C, Westwood F R, Walker M, Hughes G D, Davis P D, Ashton S E, Ryan A J. Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. Clinical Cancer Research 2002; 8: 1974–1983
   PubMed Web of Science ®Google Scholar
• Bos R, Der Hoeven J J, van der Wall E, van der G P, van Diest P J, Comans E F, Joshi U, Semenza G L, Hoekstra O S, Lammertsma A A, Molthoff C F. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. Journal of Clinical Oncology 2002; 20: 379–387
   PubMed Web of Science ®Google Scholar
• Bos R, van der Groep P, Greijer A E, Shvarts A, Meijer S, Pinedo H M, Semenza G L, van Diest P J, van der Wall E. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003; 97: 1573–1581
   PubMed Web of Science ®Google Scholar
• Bourke V, Gilio J, Zhao D, Constantinescu A, Kodibager V, Jiang L, Hahn E W, Mason R P. Correlation of tumor oxygen dynamics with radiation response of the Dunning prostate R3327-AT1 tumor. Presented at the 51st Annual Meeting of the Radiation Research Society, St. Louis, MO, 2004
   Google Scholar
• Brizel D M, Dodge R K, Clough R W, Dewhirst M W. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiotherapy and Oncology 1999; 53: 113–117
   PubMed Web of Science ®Google Scholar
• Brizel D M, Scully S P, Harrelson J M, Layfield L J, Bean J M, Prosnitz L R, Dewhirst M W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research 1996; 56: 941–943
   PubMed Web of Science ®Google Scholar
• Brown J M. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. British Journal of Cancer 1993; 67: 1163–1170
   PubMed Web of Science ®Google Scholar
• Brown J M. Tumor microenvironment and the response to anticancer therapy. Cancer Biology and Therapy 2002; 1: 453–458
   PubMed Web of Science ®Google Scholar
• Brown J M, Lemmon M J. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors. Cancer Research 1990; 50: 7745–7749
   PubMed Web of Science ®Google Scholar
• Brown J M, Yu N Y, Brown D M, Lee W W. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use. International Journal of Radiation Oncology, Biology, Physics 1981; 7: 695–703
   PubMed Web of Science ®Google Scholar
• Brune B, Zhou J. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Current Medicinal Chemistry 2003; 10: 845–855
   PubMed Web of Science ®Google Scholar
• Burai L, Scopelliti R, Toth E. EuII-cryptate with optimal water exchange and electronic relaxation: a synthon for potential pO2 responsive macromolecular MRI contrast agents. Chemical Communications (Cambridge, England) 2002; 20: 2366–2367
   Google Scholar
• Burai L, Toth E, Seibig S, Scopelliti R, Merbach A E. Solution and solid-state characterization of Eu(II) chelates: a possible route towards redox responsive MRI contrast agents. Chemistry 2000; 6: 3761–3770
   PubMedGoogle Scholar
• Cairns R A, Hill R P. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Research 2004; 64: 2054–2061
   PubMed Web of Science ®Google Scholar
• Cairns R A, Kalliomaki T, Hill R P. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Research 2001; 61: 8903–8908
   PubMed Web of Science ®Google Scholar
• Caravan P, Cloutier N J, Greenfield M T, McDermid S A, Dunham S U, Bulte J W, Amedio J C, Jr, Looby R J, Supkowski R M, Horrocks W D, Jr, McMurry T J, Lauffer R B. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. Journal of the American Chemical Society 2002; 124: 3152–3162
   PubMed Web of Science ®Google Scholar
• Carnell D M, Taylor N J, Smith R E, Hoskin P J, Stirling J J, d'Arcy J A, Walker-Samuel S, Collins D J, Leach M O, Padhani A R. Evaluation of prostate gland hypoxia with quantified BOLD MRI: updated results from a correlated histological study. Abstract No 270. Proceedings of the International Society of Magnetic Resonance in Medicine, 13th Scientific Meeting and Exhibition, Miami, FL, 2005
   Google Scholar
• Chambers A F, Wilson S M, Kerkvliet N, O'Malley F P, Harris J F, Casson A G. Osteopontin expression in lung cancer. Lung Cancer 1996; 15: 311–323
   PubMed Web of Science ®Google Scholar
• Chao K S, Bosch W R, Mutic S, Lewis J S, Dehdashti F, Mintun M A, Dempsey J F, Perez C A, Purdy J A, Welch M J. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2001; 49: 1171–1182
   PubMed Web of Science ®Google Scholar
• Chapman J D. Hypoxic sensitizers – implications for radiation therapy. New England Journal of Medicine 1979; 301: 1429–1432
   PubMed Web of Science ®Google Scholar
• Chapman J D, Coia Lr, Stobbe C C, Engelhardt E L, Fenning M C, Schneider R F. Prediction of tumour hypoxia and radioresistance with nuclear medicine markers. British Journal of Cancer Supplement 1996; 27: S204–S208
   PubMedGoogle Scholar
• Chapman J D, Franko A J, Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. British Journal of Cancer 1981; 43: 546–550
   PubMed Web of Science ®Google Scholar
• Checkley D, Tessier J J, Kendrew J, Waterton J C, Wedge S R. Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. British Journal of Cancer 2003; 89: 1889–1895
   PubMed Web of Science ®Google Scholar
• Chella A, Lucchi M, Ambrogi M C, Menconi G, Melfi F M, Gonfiotti A, Boni G, Angeletti C A. A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection. European Journal of Cardio-thoracic Surgery 2000; 18: 17–21
   PubMed Web of Science ®Google Scholar
• Clark L C, Jr, Ackerman J, Thomas S R, Millard R W, Hoffmann R E, Pratt R G, Ragle-Cole H, Kinsey R A, Janakiraman R. Perfluorinated organic liquids and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygen. Oxygen Transport to Tissue VI, D Bruley, H I Bicher, D Reneau. Plenum, New York 1984; 835–845
   Google Scholar
• Clavo B, Robaina F, Morera J, Ruiz-Egea E, Perez J L, Macias D, Carames M A, Catala L, Hernandez M A, Gunderoth M. Increase of brain tumor oxygenation during cervical spinal cord stimulation. Report of three cases. Journal of Neurosurgery Spine 2002; 96: 94–100
   PubMed Web of Science ®Google Scholar
• Collingridge D R, Piepmeier J M, Rockwell S, Knisely J P. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiotherapy and Oncology 1999; 53: 127–131
   PubMed Web of Science ®Google Scholar
• Cruickshank G S, Rampling R P, Cowans W. Direct measurement of the PO2 distribution in human malignant brain tumours. Advances in Experimental Medicine and Biology 1994; 345: 465–470
   PubMedGoogle Scholar
• Cvetkovic D, Movsas B, Dicker A P, Hanlon A L, Greenberg R E, Chapman J D, Hanks G E, Tricoli J V. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology 2001; 57: 821–825
   PubMed Web of Science ®Google Scholar
• d'Asseler Y M, Koole M, Lemahieu I, Achten E, Boon P, De Deyn P P, Dierckx R A. Recent and future evolutions in NeuroSPECT with particular emphasis on the synergistic use and fusion of imaging modalities. Acta Neurologica Belgica 1997; 97: 154–162
   PubMed Web of Science ®Google Scholar
• Dafni H, Landsman L, Schechter B, Kohen F, Neeman M. MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR in Biomedicine 2002; 15: 120–131
   PubMedGoogle Scholar
• Daldrup-Link H E, Shames D M, Wendland M, Muhler A, Gossmann A, Rosenau R, Brasch R C. Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging. Academic Radiology 2000; 7: 934–944
   PubMed Web of Science ®Google Scholar
• Daniels J S, Gates K S. DNA cleavage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (SR4233): Evidence for involvement of hydroxyl radical. Journal of the American Chemical Society 1996; 118: 3380–3385
   Web of Science ®Google Scholar
• Das R, Mahabeleshwar G H, Kundu G C. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells. Journal of Biological Chemistry 2004; 279: 11051–11064
   PubMed Web of Science ®Google Scholar
• De Jaeger K, Kavanagh M C, Hill R P. Relationship of hypoxia to metastatic ability in rodent tumours. British Journal of Cancer 2001; 84: 1280–1285
   PubMed Web of Science ®Google Scholar
• Dearling J L, Lewis J S, Mullen G E, Welch M J, Blower P J. Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships. Journal of Biological Inorganic Chemistry 2002; 7: 249–259
   PubMed Web of Science ®Google Scholar
• Degani H, Chetrit-Dadiani M, Bogin L, Furman-Haran E. Magnetic resonance imaging of tumor vasculature. Thrombosis and Haemostasis 2003; 89: 25–33
   PubMedGoogle Scholar
• Dehdashti F, Grigsby P W, Mintun M A, Lewis J S, Siegel B A, Welch M J. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. International Journal of Radiation Oncology, Biology, Physics 2003a; 55: 1233–1238
   PubMed Web of Science ®Google Scholar
• Dehdashti F, Mintun M A, Lewis J S, Bradley J, Govindan R, Laforest R, Welch M J, Siegel B A. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM. European Journal of Nuclear Medicine and Molecular Imaging 2003b; 30: 844–850
   PubMed Web of Science ®Google Scholar
• Del Rowe J, Scott C, Werner-Wasik M, Bahary J P, Curran W J, Urtasun R C, Fisher B. Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme. Journal of Clinical Oncology 2000; 18: 1254–1259
   PubMed Web of Science ®Google Scholar
• Delpuech J J, Hamza M A, Serratice G, Stebe M J. Fluorocarbons as oxygen carriers. I. An NMR study of oxygen solutions in hexafluorobenzene. Journal of Chemical Physics 1979; 70: 2680–2687
   Google Scholar
• Dewhirst M W, Tso C Y, Oliver R, Gustafson C S, Secomb T W, Gross J F. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. International Journal of Radiation Oncology, Biology, Physics 1989; 17: 91–99
   PubMed Web of Science ®Google Scholar
• Doherty N, Hancock S L, Kaye S, Coleman C N, Shulman L, Marquez C, Mariscal C, Rampling R, Senan S, Roemeling R V. Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation. International Journal of Radiation Oncology, Biology, Physics 1994; 29: 379–382
   PubMed Web of Science ®Google Scholar
• Dolbier W R, Jr, Li A R, Koch C J, Shiue C Y, Kachur A V. [18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. Applied Radiation and Isotopes 2001; 54: 73–80
   PubMed Web of Science ®Google Scholar
• Doll C M, Milosevic M, Pintilie M, Hill R P, Fyles A W. Estimating hypoxic status in human tumors: a simulation using Eppendorf oxygen probe data in cervical cancer patients. International Journal of Radiation Oncology, Biology, Physics 2003; 55: 1239–1246
   PubMed Web of Science ®Google Scholar
• Dorie M J, Brown J M. Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin. Cancer Research 1993; 53: 4633–4636
   PubMed Web of Science ®Google Scholar
• Dorie M J, Brown J M. Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine. Cancer Chemotherapy and Pharmacology 1997; 39: 361–366
   PubMed Web of Science ®Google Scholar
• Dunst J, Stadler P, Becker A, Kuhnt T, Lautenschlager C, Molls M, Haensgen G. Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers. Strahlentherapie und Onkologie 2001; 177: 469–473
   PubMedGoogle Scholar
• Durand R E. Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. International Journal of Radiation Oncology, Biology, Physics 1991; 20: 253–258
   PubMed Web of Science ®Google Scholar
• Durand R E, Olive P L. Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice. Radiation Oncology Investigations 1997; 5: 213–219
   PubMedGoogle Scholar
• Dvorak H F, Nagy J A, Feng D, Brown L F, Dvorak A M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Current Topics in Microbiology and Immunology 1999; 237: 97–132
   PubMed Web of Science ®Google Scholar
• Earls J P, Bluemke D A. New MR imaging contrast agents. Magnetic Resonance Imaging Clinics of North America 1999; 7: 255–273
   PubMedGoogle Scholar
• Elson D A, Thurston G, Huang L E, Ginzinger D G, McDonald D M, Johnson R S, Arbeit J M. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes and Development 2001; 15: 2520–2532
   PubMed Web of Science ®Google Scholar
• Elwell J H, Siim B G, Evans J W, Brown J M. Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity. Biochemical Pharmacology 1997; 54: 249–257
   PubMed Web of Science ®Google Scholar
• Engelhardt E L, Schneider R F, Seeholzer S H, Stobbe C C, Chapman J D. The synthesis and radiolabeling of 2-nitroimidazole derivatives of cyclam and their preclinical evaluation as positive markers of tumor hypoxia. Journal of Nuclear Medicine 2002; 43: 837–850
   PubMedGoogle Scholar
• Evans S M, Jenkins W T, Joiner B, Lord E M, Koch C J. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Research 1996; 56: 405–411
   PubMed Web of Science ®Google Scholar
• Evans S M, Judy K D, Dunphy I, Jenkins W T, Hwang W T, Nelson P T, Lustig R A, Jenkins K, Magarelli D P, Hahn S M, Collins R A, Grady M S, Koch C J. Hypoxia is important in the biology and aggression of human glial brain tumors. Clinical Cancer Research 2004a; 10: 8177–8184
   PubMed Web of Science ®Google Scholar
• Evans S M, Judy K D, Dunphy I, Jenkins W T, Nelson P T, Collins R, Wileyto E P, Jenkins K, Hahn S M, Stevens C W, Judkins A R, Phillips P, Geoerger B, Koch C J. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Research 2004b; 64: 1886–1892
   PubMed Web of Science ®Google Scholar
• Falk S J, Ward R, Bleehen N M. The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography. British Journal of Cancer 1992; 66: 919–924
   PubMed Web of Science ®Google Scholar
• Feng D, Nagy J A, Hipp J, Dvorak H F, Dvorak A M. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. Journal of Experimental Medicine 1996; 183: 1981–1986
   PubMed Web of Science ®Google Scholar
• Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. Journal of Nuclear Medicine 1997; 38: 1155–1160
   PubMed Web of Science ®Google Scholar
• Fukuda R, Hirota K, Fan F, Jung Y D, Ellis L M, Semenza G L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. Journal of Biological Chemistry 2002; 277: 38205–38211
   PubMed Web of Science ®Google Scholar
• Fukuda R, Kelly B, Semenza G L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Research 2003; 63: 2330–2334
   PubMed Web of Science ®Google Scholar
• Furman-Haran E, Margalit R, Maretzek A F, Degani H. Angiogenic response of MCF7 human breast cancer to hormonal treatment: assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution. Journal of Magnetic Resonance Imaging 1996; 6: 195–202
   PubMedGoogle Scholar
• Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill R P. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. Journal of Clinical Oncology 2002; 20: 680–687
   PubMed Web of Science ®Google Scholar
• Gaillard S, Kubiak C, Stolz C, Bonnemain B, Chassard D. Safety and pharmacokinetics of p792, a new blood-pool agent: Results of clinical testing in nonpatient volunteers. Investigative Radiology 2002; 37: 161–166
   PubMedGoogle Scholar
• Galbraith S M, Lodge M A, Taylor N J, Rustin G J, Bentzen S, Stirling J J, Padhani A R. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: Comparison of quantitative and semi-quantitative analysis. NMR in Biomedicine 2002; 15: 132–142
   PubMed Web of Science ®Google Scholar
• Gallez B, Baudelet C, Jordan B F. Assessment of tumor oxygenation by electron paramagnetic resonance: Principles and applications. NMR in Biomedicine 2004; 17: 240–262
   PubMed Web of Science ®Google Scholar
• Garcia-Martin M L, Herigault G, Remy C, Farion R, Ballesteros P, Coles J A, Cerdan S, Ziegler A. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: Comparison with maps of metabolites. Cancer Research 2001; 61: 6524–6531
   PubMedGoogle Scholar
• Garrecht B M, Chapman J D. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole. British Journal of Radiology 1983; 56: 745–753
   PubMedGoogle Scholar
• Geyer R P. Bloodless rats through the use of artificial blood substitutes. Federation Proceedings 1975; 34: 1499–1505
   PubMedGoogle Scholar
• Gillies R J, Raghunand N, Garcia-Martin M L, Gatenby R A. pH imaging. A review of pH measurement methods and applications in cancers. IEEE Engineering in Medicine and Biology Magazine 2004; 23: 57–64
   PubMedGoogle Scholar
• Gillies R J, Raghunand N, Karczmar G S, Bhujwalla Z M. MRI of the tumor microenvironment. Journal of Magnetic Resonance Imaging 2002; 16: 430–450
   PubMed Web of Science ®Google Scholar
• Gokhale A S, Haddad R I, Cavacini L A, Wirth L, Weeks L, Hallar M, Faucher J, Posner M R. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncology 2005; 41: 70–76
   PubMed Web of Science ®Google Scholar
• Golman K, Ardenkjaer-Larsen J H, Petersson J S, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proceedings of the National Academy of Sciences of the United States of America 2003; 100: 10435–10439
   PubMed Web of Science ®Google Scholar
• Graham M A, Senan S, Robin H, Jr, Eckhardt N, Lendrem D, Hincks J, Greenslade D, Rampling R, Kaye S B, von Roemeling R, Workman P. Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: Retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial. Cancer Chemotherapy and Pharmacology 1997; 40: 1–10
   PubMed Web of Science ®Google Scholar
• Grinberg O Y, Smirnov A I, Swartz H M. High spatial resolution multi-site EPR oximetry. The use of convolution-based fitting method. Journal of Magnetic Resonance 2001; 152: 247–258
   PubMedGoogle Scholar
• Grinberg V O, Smirnov A I, Grinberg O Y, Grinberg S A, O'Hara J A, Swartz H M. Practical experimental conditions and limitations for high spatial resolution multi-site EPR oximetry. Applied Magnetic Resonance 2005; 28: 69–78
   Google Scholar
• Gross S, Gilead A, Scherz A, Neeman M, Salomon Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nature Medicine 2003; 9: 1327–1331
   PubMed Web of Science ®Google Scholar
• Hall E J. Radiobiology for the radiologist. Lippincott Willams & Wilkins, Philadelphia 2000
   Google Scholar
• Hampel D J, Sansome C, Romanov V I, Kowalski A J, Denhardt D T, Goligorsky M S. Osteopontin traffic in hypoxic renal epithelial cells. Nephron Experimental Nephrology 2003; 94: e66–e76
   Google Scholar
• Haugland H K, Vukovic V, Pintilie M, Fyles A W, Milosevic M, Hill R P, Hedley D W. Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: Correlation with tumor oxygenation. International Journal of Radiation Oncology, Biology, Physics 2002; 53: 854–861
   PubMed Web of Science ®Google Scholar
• Hayes C, Padhani A R, Leach M O. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR in Biomedicine 2002; 15: 154–163
   PubMed Web of Science ®Google Scholar
• He G, Samouilov A, Kuppusamy P, Zweier J L. In vivo imaging of free radicals: Applications from mouse to man. Molecular and Cellular Biochemistry 2002; 234 – 235: 359–367
   PubMedGoogle Scholar
• He Q, Xu R Z, Shkarin P, Pizzorno G, Lee-French C H, Rothman D L, Shungu D C, Shim H. Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment. Disease Markers 2003; 19: 69–94
   PubMedGoogle Scholar
• Hedley D, Pintilie M, Woo J, Morrison A, Birle D, Fyles A, Milosevic M, Hill R. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clinical Cancer Research 2003; 9: 5666–5674
   PubMed Web of Science ®Google Scholar
• Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett N R, Crystal R G, Besmer P, Lyden D, Moore M A, Werb Z, Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625–637
   PubMed Web of Science ®Google Scholar
• Helbich T H, Roberts T P, Gossmann A, Wendland M F, Shames D M, Adachi M, Yang S, Huber S, Daldrup H, Brasch R C. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods. Magnetic Resonance in Medicine 2000; 44: 915–924
   PubMedGoogle Scholar
• Hill R P, De Jaeger K, Jang A, Cairns R. pH, hypoxia and metastasis. Novartis Foundation Symposium 2001; 240: 154–165
   PubMedGoogle Scholar
• Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research 1996; 56: 4509–4515
   PubMed Web of Science ®Google Scholar
• Hockel M, Vaupel P. Biological consequences of tumor hypoxia. Seminars in Oncology 2001a; 28: 36–41
   PubMed Web of Science ®Google Scholar
• Hockel M, Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. Journal of the National Cancer Institute 2001b; 93: 266–276
   PubMed Web of Science ®Google Scholar
• Hockel S, Schlenger K, Vaupel P, Hockel M. Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer. International Journal of Oncology 2001; 19: 827–832
   PubMedGoogle Scholar
• Hoffman J M, Rasey J S, Spence A M, Shaw D W, Krohn K A. Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia. Stroke 1987; 18: 168–176
   PubMedGoogle Scholar
• Hofmann M, Maecke H, Borner R, Weckesser E, Schoffski P, Oei L, Schumacher J, Henze M, Heppeler A, Meyer J, Knapp H. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. European Journal of Nuclear Medicine 2001; 28: 1751–1757
   PubMedGoogle Scholar
• Hohenberger P, Bida B, Schlag P M. Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan. Strahlentherapie und Onkologie 1996; 172(Suppl 2)14–15
   PubMedGoogle Scholar
• Horowitz M, Blasberg R, Molnar P, Strong J, Kornblith P, Pleasants R, Fenstermacher J. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors. Cancer Research 1983; 43: 3800–3807
   PubMed Web of Science ®Google Scholar
• Hou H, Khan N, O'Hara J A, Grinberg O Y, Dunn J F, Abajian M A, Wilmot C M, Makki M, Demidenko E, Lu S, Steffen R P, Swartz H M. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study. International Journal of Radiation Oncology, Biology, Physics 2004; 59: 834–843
   PubMedGoogle Scholar
• Howe F A, Robinson S P, McIntyre D J, Stubbs M, Griffiths J R. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR in Biomedicine 2001; 14: 497–506
   PubMed Web of Science ®Google Scholar
• Howe F A, Robinson S P, Rodrigues L M, Griffiths J R. Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magnetic Resonance Imaging 1999; 17: 1307–1318
   PubMedGoogle Scholar
• Hui E P, Chan A T, Pezzella F, Turley H, To K F, Poon T C, Zee B, Mo F, Teo P M, Huang D P, Gatter K C, Johnson P J, Harris A L. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clinical Cancer Research 2002; 8: 2595–2604
   PubMed Web of Science ®Google Scholar
• Hunjan S, Zhao D, Constantinescu A, Hahn E W, Antich P P, Mason R P. Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. International Journal of Radiation Oncology, Biology, Physics 2001; 49: 1097–1108
   PubMed Web of Science ®Google Scholar
• Jackson S K, Thomas M P, Smith S, Madhani M, Rogers S C, James P E. In vivo EPR spectroscopy: biomedical and potential diagnostic applications. Faraday Discussions 2004; 126: 103–117
   PubMedGoogle Scholar
• James P E, Thomas M P, Jackson S K. Tissue oxygenation in sepsis; new insights from in vivo EPR. NMR in Biomedicine 2004; 17: 319–326
   PubMedGoogle Scholar
• Jette D C, Wiebe L I, Flanagan R J, Lee J, Chapman J D. Iodoazomycin riboside (1-(5′-iodo-5′-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization. Radiation Research 1986; 105: 169–179
   PubMedGoogle Scholar
• Jordan B F, Runquist M, Raghunand N, Baker A, Williams R, Kirkpatrick L, Powis G, Gillies R J. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia 2005; 7: 475–485
   PubMedGoogle Scholar
• Joseph P, Jaiswal A K, Stobbe C C, Chapman J D. The role of specific reductases in the intracellular activation and binding of 2-nitroimidazoles. International Journal of Radiation Oncology, Biology, Physics 1994; 29: 351–355
   PubMedGoogle Scholar
• Joseph P M, Fishman J E, Mukherji B, Sloviter H A. In vivo 19F NMR imaging of the cardiovascular system. Journal of Computer Assisted Tomography 1985; 9: 1012–1019
   PubMed Web of Science ®Google Scholar
• Jung Y J, Isaacs J S, Lee S, Trepel J, Neckers L. Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein. Journal of Biological Chemistry 2003; 278: 7445–7452
   PubMed Web of Science ®Google Scholar
• Kaanders J H, Wijffels K I, Marres H A, Ljungkvist A S, Pop L A, van den Hoogen F J, de Wilde P C, Bussink J, Raleigh J A, van der Kogel A J. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Research 2002; 62: 7066–7074
   PubMed Web of Science ®Google Scholar
• Kallinowski F, Eble M J, Buhr H J, Wannenmacher M, Herfarth C. Intraoperative radiotherapy for primary and recurrent rectal cancer. European Journal of Surgical Oncology 1995; 21: 191–194
   PubMedGoogle Scholar
• Kallinowski F, Zander R, Hoeckel M, Vaupel P. Tumor tissue oxygenation as evaluated by computerized-pO2-histography. International Journal of Radiation Oncology, Biology, Physics 1990; 19: 953–961
   PubMed Web of Science ®Google Scholar
• Karam J A, Mason R P, Koeneman K S, Antich P P, Benaim E A, Hsieh J T. Molecular imaging in prostate cancer. Journal of Cellular Biochemistry 2003; 90: 473–483
   PubMedGoogle Scholar
• Kavanagh M C, Tsang V, Chow S, Koch C, Hedley D, Minkin S, Hill R P. A comparison in individual murine tumors of techniques for measuring oxygen levels. International Journal of Radiation Oncology, Biology, Physics 1999; 44: 1137–1146
   PubMedGoogle Scholar
• Kelly B D, Hackett S F, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro P A, Semenza G L. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circulation Research 2003; 93: 1074–1081
   PubMed Web of Science ®Google Scholar
• Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M, Helman L. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clinical and Experimental Metastasis 2000; 18: 261–271
   PubMed Web of Science ®Google Scholar
• Kimura H, Braun R D, Ong E T, Hsu R, Secomb T W, Papahadjopoulos D, Hong K, Dewhirst M W. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Research 1996; 56: 5522–5528
   PubMed Web of Science ®Google Scholar
• Knocke T H, Weitmann H D, Feldmann H J, Selzer E, Potter R. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiotherapy and Oncology 1999; 53: 99–104
   PubMed Web of Science ®Google Scholar
• Knopp M V, Giesel F L, Marcos H, Tengg-Kobligk H, Choyke P. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Topics in Magnetic Resonance Imaging 2001; 12: 301–308
   PubMedGoogle Scholar
• Koch C J. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin. Cancer Research 1993; 53: 3992–3997
   PubMed Web of Science ®Google Scholar
• Koch C J. Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. Methods in Enzymology 2002; 352: 3–31
   PubMed Web of Science ®Google Scholar
• Koch C J, Evans S M, Lord E M. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide]: Analysis of drug adducts by fluorescent antibodies vs bound radioactivity. British Journal of Cancer 1995; 72: 869–874
   PubMed Web of Science ®Google Scholar
• Koch C J, Hahn S M, Rockwell K, Jr, Covey J M, McKenna W G, Evans S M. Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: Implications for hypoxia measurements in vivo by 2-nitroimidazoles. Cancer Chemotherapy and Pharmacology 2001; 48: 177–187
   PubMedGoogle Scholar
• Kodibagkar V D, Cui W, Merritt M E, Mason R P. A novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane. Magnetic Resonance in Medicine 2006; 55: 743–748
   PubMedGoogle Scholar
• Koh W J, Bergman K S, Rasey J S, Peterson L M, Evans M L, Graham M M, Grierson J R, Lindsley K L, Lewellen T K, Krohn K A, Griffin T W. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. International Journal of Radiation Oncology, Biology, Physics 1995; 33: 391–398
   PubMed Web of Science ®Google Scholar
• Koong A C, Mehta V K, Le Q T, Fisher G A, Terris D J, Brown J M, Bastidas A J, Vierra M. Pancreatic tumors show high levels of hypoxia. International Journal of Radiation Oncology, Biology, Physics 2000; 48: 919–922
   PubMed Web of Science ®Google Scholar
• Koukourakis M I, Giatromanolaki A, Sivridis E, Simopoulos K, Pastorek J, Wykoff C C, Gatter K C, Harris A L. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clinical Cancer Research 2001; 7: 3399–3403
   PubMed Web of Science ®Google Scholar
• Kovacs M S, Hocking D J, Evans J W, Siim B G, Wouters B G, Brown J M. Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin. British Journal of Cancer 1999; 80: 1245–1251
   PubMed Web of Science ®Google Scholar
• Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate K H. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 2000; 19: 5435–5443
   PubMed Web of Science ®Google Scholar
• Krishna M C, Devasahayam N, Cook J A, Subramanian S, Kuppusamy P, Mitchell J B. Electron paramagnetic resonance for small animal imaging applications. ILAR Journal 2001a; 42: 209–218
   PubMedGoogle Scholar
• Krishna M C, English S, Yamada K, Yoo J, Murugesan R, Devasahayam N, Cook J A, Golman K, Ardenkjaer-Larsen J H, Subramanian S, Mitchell J B. Overhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 2216–2221
   PubMed Web of Science ®Google Scholar
• Krishna M C, Subramanian S, Kuppusamy P, Mitchell J B. Magnetic resonance imaging for in vivo assessment of tissue oxygen concentration. Seminars in Radiation Oncology 2001b; 11: 58–69
   PubMed Web of Science ®Google Scholar
• Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza G L. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Research 2003; 63: 1138–1143
   PubMed Web of Science ®Google Scholar
• Lartigau E, Randrianarivelo H, Avril M F, Margulis A, Spatz A, Eschwege F, Guichard M. Intratumoral oxygen tension in metastatic melanoma. Melanoma Research 1997; 7: 400–406
   PubMed Web of Science ®Google Scholar
• Laughner E, Taghavi P, Chiles K, Mahon P C, Semenza G L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Molecular and Cellular Biology 2001; 21: 3995–4004
   PubMed Web of Science ®Google Scholar
• Le D, Mason R P, Hunjan S, Constantinescu A, Barker B R, Antich P P. Regional tumor oxygen dynamics: 19F PBSR EPI of hexafluorobenzene. Magnetic Resonance Imaging 1997; 15: 971–981
   PubMed Web of Science ®Google Scholar
• Le Q T, Kovacs M S, Dorie M J, Koong A, Terris D J, Pinto H A, Goffinet D R, Nowels K, Bloch D, Brown J M. Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. International Journal of Radiation Oncology, Biology, Physics 2003a; 56: 375–383
   PubMedGoogle Scholar
• Le Q T, Sutphin P D, Raychaudhuri S, Yu S C, Terris D J, Lin H S, Lum B, Pinto H A, Koong A C, Giaccia A J. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clinical Cancer Research 2003b; 9: 59–67
   PubMed Web of Science ®Google Scholar
• Lee D J, Trotti A, Spencer S, Rostock R, Fisher C, von Roemeling R, Harvey E, Groves E. Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study. International Journal of Radiation Oncology, Biology, Physics 1998; 42: 811–815
   PubMed Web of Science ®Google Scholar
• Lewis J S, Herrero P, Sharp T L, Engelbach J A, Fujibayashi Y, Laforest R, Kovacs A, Gropler R J, Welch M J. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). Journal of Nuclear Medicine 2002; 43: 1557–1569
   PubMed Web of Science ®Google Scholar
• Lewis J S, McCarthy D W, McCarthy T J, Fujibayashi Y, Welch M J. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. Journal of Nuclear Medicine 1999; 40: 177–183
   PubMed Web of Science ®Google Scholar
• Lewis J S, Sharp T L, Laforest R, Fujibayashi Y, Welch M J. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): Effect of changes in tissue oxygenation. Journal of Nuclear Medicine 2001; 42: 655–661
   PubMed Web of Science ®Google Scholar
• Li P, Oparil S, Feng W, Chen Y F. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. Journal of Applied Physiology 2004; 97: 1550–1558
   PubMed Web of Science ®Google Scholar
• Liptay M J, Masters G A, Winchester D J, Edelman B L, Garrido B J, Hirschtritt T R, Perlman R M, Fry W A. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Annals of Thoracic Surgery 2000; 70: 384–389
   PubMed Web of Science ®Google Scholar
• Ljunggren K, Strand S E. Beta camera for static and dynamic imaging of charged-particle emitting radionuclides in biologic samples. Journal of Nuclear Medicine 1990; 31: 2058–2063
   PubMed Web of Science ®Google Scholar
• Loncaster J A, Harris A L, Davidson S E, Logue J P, Hunter R D, Wycoff C C, Pastorek J, Ratcliffe P J, Stratford I J, West C M. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Research 2001; 61: 6394–6399
   PubMed Web of Science ®Google Scholar
• Lord E M, Harwell L, Koch C J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Research 1993; 53: 5721–5726
   PubMedGoogle Scholar
• Lu Z R, Parker D L, Goodrich K C, Wang X, Dalle J G, Buswell H R. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI. Magnetic Resonance in Medicine 2004; 51: 27–34
   PubMed Web of Science ®Google Scholar
• Lu Z R, Wang X, Parker D L, Goodrich K C, Buswell H R. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. Bioconjugate Chemistry 2003; 14: 715–719
   PubMed Web of Science ®Google Scholar
• Lukiw W J, Ottlecz A, Lambrou G, Grueninger M, Finley J, Thompson H W, Bazan N G. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Investigative Ophthalmology and Visual Science 2003; 44: 4163–4170
   PubMed Web of Science ®Google Scholar
• Lyng H, Sundfor K, Trope C, Rofstad E K. Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clinical Cancer Research 2000; 6: 1104–1112
   PubMed Web of Science ®Google Scholar
• Mabjeesh N J, Escuin D, LaVallee T M, Pribluda V S, Swartz G M, Johnson M S, Willard M T, Zhong H, Simons J W, Giannakakou P. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003; 3: 363–375
   PubMed Web of Science ®Google Scholar
• Macpherson G R, Figg W D. Small molecule-mediated anti-cancer therapy via Hypoxia-Inducible Factor-1 blockade. Cancer Biology and Therapy 2004; 3: 503–504
   PubMed Web of Science ®Google Scholar
• Mannan R H, Mercer J R, Wiebe L I, Kumar P, Somayaji V V, Chapman J D. Radioiodinated azomycin pyranoside (IAZP): a novel non-invasive marker for the assessment of tumor hypoxia. Journal of Nuclear Biology and Medicine 1992; 36: 60–67
   PubMedGoogle Scholar
• Martin G V, Caldwell J H, Rasey J S, Grunbaum Z, Cerqueira M, Krohn K A. Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium. Journal of Nuclear Medicine 1989; 30: 194–201
   PubMed Web of Science ®Google Scholar
• Mason R P. Non-invasive physiology: 19F NMR of perfluorocarbons. Artificial Cells, Blood Substitutes and Immobilization Biotechnology 1994; 22: 1141–1153
   PubMed Web of Science ®Google Scholar
• Mason R P, Antich P P, Babcock E E, Constantinescu A, Peschke P, Hahn E W. Non-invasive determination of tumor oxygen tension and local variation with growth. International Journal of Radiation Oncology, Biology, Physics 1994; 29: 95–103
   PubMed Web of Science ®Google Scholar
• Mason R P, Antich P P, Babcock E E, Gerberich J L, Nunnally R L. Perfluorocarbon imaging in vivo: a 19F MRI study in tumor-bearing mice. Magnetic Resonance Imaging 1989; 7: 475–485
   PubMed Web of Science ®Google Scholar
• Mason R P, Constantinescu A, Hunjan S, Le D, Hahn E W, Antich P P, Blum C, Peschke P. Regional tumor oxygenation and measurement of dynamic changes. Radiation Research 1999; 152: 239–249
   PubMed Web of Science ®Google Scholar
• Mason R P, Hunjan S, Constantinescu A, Song Y, Zhao D, Hahn E W, Antich P P, Peschke P. Tumor oximetry: comparison of 19F MR EPI and electrodes. Oxygen Transport to Tissue XXIV, H M Swartz, J F Dunn. Plenum, New York 2003; 19–28
   Google Scholar
• Mason R P, Ran S, Thorpe P E. Quantitative assessment of tumor oxygen dynamics: molecular imaging for prognostic radiology. Journal of Cellular Biochemistry Supplement 2002; 39: 45–53
   PubMedGoogle Scholar
• Mason R P, Rodbumrung W, Antich P P. Hexafluorobenzene: A sensitive 19F NMR indicator of tumor oxygenation. NMR in Biomedicine 1996; 9: 125–134
   PubMed Web of Science ®Google Scholar
• Masuda K, Ono M, Okamoto M, Morikawa W, Otsubo M, Migita T, Tsuneyoshi M, Okuda H, Shuin T, Naito S, Kuwano M. Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells. International Journal of Cancer 2003; 105: 803–810
   PubMed Web of Science ®Google Scholar
• Mattern J, Kallinowski F, Herfarth C, Volm M. Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. International Journal of Cancer 1996; 67: 20–23
   PubMedGoogle Scholar
• Maurer R I, Blower P J, Dilworth J R, Reynolds C A, Zheng Y, Mullen G E. Studies on the mechanism of hypoxic selectivity in copper bis(thiosemicarbazone) radiopharmaceuticals. Journal of Medicine and Chemistry 2002; 45: 1420–1431
   PubMedGoogle Scholar
• Maxwell P H. HIF-1's relationship to oxygen: simple yet sophisticated. Cell Cycle 2004; 3: 156–159
   PubMedGoogle Scholar
• Maxwell P H, Wiesener M S, Chang G W, Clifford S C, Vaux E C, Cockman M E, Wykoff C C, Pugh C W, Maher E R, Ratcliffe P J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999a; 399: 271–275
   PubMed Web of Science ®Google Scholar
• Maxwell R J, Robinson S P, McIntyre D J, Griffiths J R, Vojnovic B. Comparison of changes in gradient echo 1H MR image intensity and pO2 in rodent tumours in response to carbogen breathing. Proceedings of the 7th International Society of Magnetic Resonance in Medicine. 1999b; 495
   Google Scholar
• Maxwell R J, Wilson J, Prise V E, Vojnovic B, Rustin G J, Lodge M A, Tozer G M. Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI. NMR in Biomedicine 2002; 15: 89–98
   PubMed Web of Science ®Google Scholar
• McCarthy D W, Bass L A, Cutler P D, Shefer R E, Klinkowstein R E, Herrero P, Lewis J S, Cutler C S, Anderson C J, Welch M J. High purity production and potential applications of copper-60 and copper-61. Nuclear Medicine and Biology 1999; 26: 351–358
   PubMedGoogle Scholar
• McDonald D M, Choyke P L. Imaging of angiogenesis: From microscope to clinic. Nature Medicine 2003; 9: 713–725
   PubMed Web of Science ®Google Scholar
• McIntyre D JO, McCoy C L, Griffiths J R. Tumour oxygenation measurements by 19F MRI of perfluorocarbons. Current Science 1999; 76: 753–762
   Web of Science ®Google Scholar
• McKenna D, Iqbal A, O'keeffe D. Tc-99m methylene diphosphonate uptake in a primary lung cancer. Clinical Nuclear Medicine 2004; 29: 723–724
   PubMedGoogle Scholar
• Medico E, Gentile A, Lo C C, Williams T A, Gambarotta G, Trusolino L, Comoglio P M. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth. Cancer Research 2001; 61: 5861–5868
   PubMed Web of Science ®Google Scholar
• Milosevic M, Fyles A, Hill R. Interstitial fluid pressure in cervical cancer: Guide to targeted therapy. American Journal of Clinical Oncology 2001; 24: 516–521
   PubMedGoogle Scholar
• Minet E, Michel G, Mottet D, Raes M, Michiels C. Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radical Biology and Medicine 2001; 31: 847–855
   PubMed Web of Science ®Google Scholar
• Mishima H, Kobayashi T, Shimizu M, Tamaki Y, Baba M, Shimano T, Itoh S, Yamazaki M, Iriguchi N, Takahashi M, et al. In vivo F-19 chemical shift imaging with FTPA and antibody-coupled FMIQ. Journal of Magnetic Resonance Imaging 1991; 1: 705–709
   PubMed Web of Science ®Google Scholar
• Morawski A M, Winter P M, Yu X, Fuhrhop R W, Scott M J, Hockett F, Robertson J D, Gaffney P J, Lanza G M, Wickline S A. Quantitative magnetic resonance immunohistochemistry with ligand-targeted (19)F nanoparticles. Magnetic Resonance in Medicine 2004; 52: 1255–1262
   PubMed Web of Science ®Google Scholar
• Movsas B, Chapman J D, Hanlon A L, Horwitz E M, Greenberg R E, Stobbe C, Hanks G E, Pollack A. Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings. Urology 2002; 60: 634–639
   PubMed Web of Science ®Google Scholar
• Movsas B, Chapman J D, Horwitz E M, Pinover W H, Greenberg R E, Hanlon A L, Iyer R, Hanks G E. Hypoxic regions exist in human prostate carcinoma. Urology 1999; 53: 11–18
   PubMed Web of Science ®Google Scholar
• Neckers L. Development of small molecule Hsp90 inhibitors: Utilizing both forward and reverse chemical genomics for drug identification. Current Medicinal Chemistry 2003; 10: 733–739
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Alsner J, Keller J, Nielsen O S, Jensen O M, Horsman M R, Overgaard J. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations. British Journal of Cancer 2001; 84: 1070–1075
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiotherapy and Oncology 2000; 57: 39–43
   PubMed Web of Science ®Google Scholar
• O'Hara J A, Blumenthal R D, Grinberg O Y, Demidenko E, Grinberg S, Wilmot C M, Taylor A M, Goldenberg D M, Swartz H M. Response to radioimmunotherapy correlates with tumor pO2 measured by EPR oximetry in human tumor xenografts. Radiation Research 2001; 155: 466–473
   PubMed Web of Science ®Google Scholar
• O'Hara J A, Goda F, Demidenko E, Swartz H M. Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry. Radiation Research 1998; 150: 549–556
   PubMed Web of Science ®Google Scholar
• O-Charoenrat P, Rhys-Evans P, Eccles S A. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001; 92: 556–568
   PubMedGoogle Scholar
• Ogan M D, Schmiedl U, Moseley M E, Grodd W, Paajanen H, Brasch R C. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: Preparation and characterization. Investigative Radiology 1987; 22: 665–671
   PubMed Web of Science ®Google Scholar
• Oliver R J, Woodwards R T, Sloan P, Thakker N S, Stratford I J, Airley R E. Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection: Results of EORTC Translational Research Fund studies. European Journal of Cancer 2004; 40: 503–507
   PubMed Web of Science ®Google Scholar
• Os-Corby D J, Chapman J D. In vitro binding of 14C-misonidazole to hepatocytes and hepatoma cells. International Journal of Radiation Oncology, Biology, Physics 1986; 12: 1251–1254
   PubMedGoogle Scholar
• Os-Corby D J, Koch C J, Chapman J D. Is misonidazole binding to mouse tissues a measure of cellular pO2?. Biochemical Pharmacology 1987; 36: 3487–3494
   PubMedGoogle Scholar
• Padhani A R. Functional MRI for anticancer therapy assessment. European Journal of Cancer 2002; 38: 2116–2127
   PubMed Web of Science ®Google Scholar
• Padhani A R, Ah-See M LW, Taylor N J, Stirling J J, Daley F M, Richman P I, d'Arcy J A, Walker-Samuel S, Harris A L, Collins D J, Leach M O, Makris A. An investigation of histological and DCE-MRI correlates of intrinsic susceptibility contrast relaxivity (R2*) in human breast cancer. Poster Presentation No. 1845. Proceedings of the International Society of Magnetic Resonance in Medicine, 13th Scientific Meeting and Exhibition, Miami, FL, 2005
   Google Scholar
• Padhani A R, Taylor N J, Lankester K J, Ah-See M W, Atkin G, Carnell D M, Stirling J J, Glynne-Jones R, Makris A, Hoskin P J, d'Arcy J A, Leach M O, Rustin G JS. Heterogeneity of angiogenesis on DCE-MRI in human tumours: Implications for antiangiogenic therapies. Poster Presentation No. 1989. Proceedings of the International Society of Magnetic Resonance in Medicine, 12th Scientific Meeting, KyotoJapan, 2004
   Google Scholar
• Padhani A R, Hayes C, Landau S, Leach M O. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR in Biomedicine 2002; 15: 143–153
   PubMed Web of Science ®Google Scholar
• Padhani A R, Neeman M. Challenges for imaging angiogenesis. British Journal of Radiology 2001; 74: 886–890
   PubMed Web of Science ®Google Scholar
• Parker C, Milosevic M, Toi A, Sweet J, Panzarella T, Bristow R, Catton C, Catton P, Crook J, Gospodarowicz M, McLean M, Warde P, Hill R P. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics 2004; 58: 750–757
   PubMed Web of Science ®Google Scholar
• Parliament M B, Chapman J D, Urtasun R C, McEwan A J, Golberg L, Mercer J R, Mannan R H, Wiebe L I. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study. British Journal of Cancer 1992; 65: 90–95
   PubMed Web of Science ®Google Scholar
• Pauwels E K, Ribeiro M J, Stoot J H, McCready V R, Bourguignon M, Maziere B. FDG accumulation and tumor biology. Nuclear Medicine and Biology 1998; 25: 317–322
   PubMed Web of Science ®Google Scholar
• Peschke P, Hahn E W, Wenz F, Lohr F, Braunschweig F, Wolber G, Zuna I, Wannenmacher M. Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia. Radiation Research 1998; 150: 423–430
   PubMed Web of Science ®Google Scholar
• Peters K B, Brown J M. Tirapazamine: a hypoxia-activated topoisomerase II poison. Cancer Research 2002; 62: 5248–5253
   PubMed Web of Science ®Google Scholar
• Pichiule P, Chavez J C, LaManna J C. Hypoxic regulation of angiopoietin-2 expression in endothelial cells. Journal of Biological Chemistry 2004; 279: 12171–12180
   PubMed Web of Science ®Google Scholar
• Port M, Corot C, Raynal I, Idee J M, Dencausse A, Lancelot E, Meyer D, Bonnemain B, Lautrou J. Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. Investigative Radiology 2001a; 36: 445–454
   PubMed Web of Science ®Google Scholar
• Port R E, Knopp M V, Brix G. Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors. Magnetic Resonance in Medicine 2001b; 45: 1030–1038
   PubMed Web of Science ®Google Scholar
• Quintero M, Mackenzie N, Brennan P A. Hypoxia-inducible factor 1 (HIF-1) in cancer. European Journal of Surgical Oncology 2004; 30: 465–468
   PubMed Web of Science ®Google Scholar
• Raghunand N, Gatenby R A, Gillies R J. Microenvironmental and cellular consequences of altered blood flow in tumours. British Journal of Radiology 2003a; 76(Suppl. 1)S11–S22
   Google Scholar
• Raghunand N, Gillies R J. pH and chemotherapy. Novartis Foundation Symposium 2001; 240: 199–211
   PubMedGoogle Scholar
• Raghunand N, Howison C, Sherry A D, Zhang S, Gillies R J. Renal and systemic pH imaging by contrast-enhanced MRI. Magnetic Resonance in Medicine 2003b; 49: 249–257
   PubMedGoogle Scholar
• Rajendran J G, Mankoff D A, O'Sullivan F, Peterson L M, Schwartz D L, Conrad E U, Spence A M, Muzi M, Farwell D G, Krohn K A. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clinical Cancer Research 2004; 10: 2245–2252
   PubMed Web of Science ®Google Scholar
• Rajendran J G, Wilson D C, Conrad E U, Peterson L M, Bruckner J D, Rasey J S, Chin L K, Hofstrand P D, Grierson J R, Eary J F, Krohn K A. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. European Journal of Nuclear Medicine and Molecular Imaging 2003; 30: 695–704
   PubMed Web of Science ®Google Scholar
• Rampling R, Cruickshank G, Lewis A D, Fitzsimmons S A, Workman P. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. International Journal of Radiation Oncology, Biology, Physics 1994; 29: 427–431
   PubMed Web of Science ®Google Scholar
• Ran S, Gao B, Duffy S, Watkins L, Rote N, Thorpe P E. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature. Cancer Research 1998; 58: 4646–4653
   PubMed Web of Science ®Google Scholar
• Rapisarda A, Shoemaker R H, Melillo G. Targeting topoisomerase I to inhibit hypoxia inducible factor 1. Cell Cycle 2004a; 3: 172–175
   PubMedGoogle Scholar
• Rapisarda A, Uranchimeg B, Sordet O, Pommier Y, Shoemaker R H, Melillo G. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. Cancer Research 2004b; 64: 1475–1482
   PubMed Web of Science ®Google Scholar
• Rapisarda A, Zalek J, Hollingshead M, Braunschweig T, Uranchimeg B, Bonomi C A, Borgel S D, Carter J P, Hewitt S M, Shoemaker R H, Melillo G. Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts. Cancer Research 2004c; 64: 6845–6848
   PubMed Web of Science ®Google Scholar
• Rasey J S, Hofstrand P D, Chin L K, Tewson T J. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia. Journal of Nuclear Medicine 1999; 40: 1072–1079
   PubMed Web of Science ®Google Scholar
• Ravi D, Ramadas K, Mathew B S, Panikkar K R, Nair M K, Pillai M R. Apoptosis, angiogenesis and proliferation: trifunctional measure of tumour response to radiotherapy for oral cancer. Oral Oncology 2001; 37: 164–171
   PubMedGoogle Scholar
• Riedel F, Gotte K, Schwalb J, Wirtz H, Bergler W, Hormann K. Serum levels of vascular endothelial growth factor in patients with head and neck cancer. European Archives of Otorhinolaryngology 2000; 257: 332–336
   PubMed Web of Science ®Google Scholar
• Rijpkema M, Kaanders J H, Joosten F B, van der Kogel A J, Heerschap A. Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging. International Journal of Radiation Oncology, Biology, Physics 2002; 53: 1185–1191
   PubMedGoogle Scholar
• Rischin D, Peters L, Fisher R, Macann A, Denham J, Poulsen M, Jackson M, Kenny L, Penniment M, Corry J, Lamb D, McClure B. Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). Journal of Clinical Oncology 2005; 23: 79–87
   PubMed Web of Science ®Google Scholar
• Rischin D, Peters L, Hicks R, Hughes P, Fisher R, Hart R, Sexton M, D'Costa I, von Roemeling R. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. Journal of Clinical Oncology 2001; 19: 535–542
   PubMed Web of Science ®Google Scholar
• Roberts T P. Physiologic measurements by contrast-enhanced MR imaging: Expectations and limitations. Journal of Magnetic Resonance Imaging 1997; 7: 82–90
   PubMed Web of Science ®Google Scholar
• Robinson S P, Collingridge D R, Howe F A, Rodrigues L M, Chaplin D J, Griffiths J R. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR in Biomedicine 1999; 12: 98–106
   PubMedGoogle Scholar
• Robinson S P, Kalber T L, Howe F A, McIntyre D JO, Griffiths J R, Blakey D C, Whittaker L, Ryan A J, Waterton J C. Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging. Neoplasia 2005; 7: 466–474
   PubMedGoogle Scholar
• Robinson S P, Rodrigues L M, Ojugo A S, McSheehy P M, Howe F A, Griffiths J R. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. British Journal of Cancer 1997; 75: 1000–1006
   PubMedGoogle Scholar
• Rodrigues L M, Howe F A, Griffiths J R, Robinson S P. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors. Journal of Magnetic Resonance Imaging 2004; 19: 482–488
   PubMedGoogle Scholar
• Rudat V, Vanselow B, Wollensack P, Bettscheider C, Osman-Ahmet S, Eble M J, Dietz A. Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. Radiotherapy and Oncology 2000; 57: 31–37
   PubMedGoogle Scholar
• Rudland P S, Platt-Higgins A, El Tanani M, De Silva R S, Barraclough R, Winstanley J H, Howitt R, West C R. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Research 2002; 62: 3417–3427
   PubMedGoogle Scholar
• Runkel S, Wischnik A, Teubner J, Kaven E, Gaa J, Melchert F. Oxygenation of mammary tumors as evaluated by ultrasound-guided computerized-pO2-histography. Advances in Experimental Medicine and Biology 1994; 345: 451–458
   PubMedGoogle Scholar
• Saha G B, MacIntyre W J, Go R T. Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging. Seminars in Nuclear Medicine 1992; 22: 150–161
   PubMedGoogle Scholar
• Sanchez-Crespo A, Andreo P, Larsson S A. Positron flight in human tissues and its influence on PET image spatial resolution. European Journal of Nuclear Medicine and Molecular Imaging 2004; 31: 44–51
   PubMed Web of Science ®Google Scholar
• Scatena M, Almeida M, Chaisson M L, Fausto N, Nicosia R F, Giachelli C M. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. Journal of Cell Biology 1998; 141: 1083–1093
   PubMed Web of Science ®Google Scholar
• Schindl M, Oberhuber G, Pichlbauer E G, Obermair A, Birner P, Kelley M R. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance. International Journal of Oncology 2001; 19: 799–802
   PubMed Web of Science ®Google Scholar
• Schindl M, Schoppmann S F, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clinical Cancer Research 2002; 8: 1831–1837
   PubMed Web of Science ®Google Scholar
• Schirner M, Menrad A, Stephens A, Frenzel T, Hauff P, Licha K. Molecular imaging of tumor angiogenesis. Annals of the New York Academy of Sciences 2004; 1014: 67–75
   PubMed Web of Science ®Google Scholar
• Schmiedl U, Brasch R C, Ogan M D, Moseley M E. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. Acta Radiologica Supplement 1990; 374: 99–102
   PubMedGoogle Scholar
• Schneider S, Yochim J, Brabender J, Uchida K, Danenberg K D, Metzger R, Schneider P M, Salonga D, Holscher A H, Danenberg P V. Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer. Clinical Cancer Research 2004; 10: 1588–1596
   PubMed Web of Science ®Google Scholar
• Schornack P A, Gillies R J. Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia 2003; 5: 135–145
   PubMed Web of Science ®Google Scholar
• Schuhmacher J, Kaul S, Klivenyi G, Junkermann H, Magener A, Henze M, Doll J, Haberkorn U, Amelung F, Bastert G. Immunoscintigraphy with positron emission tomography: Gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies. Cancer Research 2001; 61: 3712–3717
   PubMed Web of Science ®Google Scholar
• Schuster D P, Markham J, Welch M J. Positron emission tomography measurements of pulmonary vascular permeability with Ga-68 transferrin or C-11 methylalbumin. Critical Care Medicine 1998; 26: 518–525
   PubMed Web of Science ®Google Scholar
• Sealy R C, Swartz H M, Olive P L. Electron spin resonance-spin trapping. Detection of superoxide formation during aerobic microsomal reduction of nitro-compounds. Biochemical and Biophysical Research Communications 1978; 82: 680–684
   PubMed Web of Science ®Google Scholar
• Secomb T W, Hsu R, Braun R D, Dewhirst M W. Analysis of oxygen transport to tumors: causes of heterogeneous tissue oxygenation. Proceedings of the 1999 Bioengineering Conference, New York. V K Goel, R L Spilker, G A Ateshian, L J Soslowsky. 1999; 487–488
   Google Scholar
• Semenza G L. Expression of hypoxia-inducible factor 1: Mechanisms and consequences. Biochemical Pharmacology 2000; 59: 47–53
   PubMed Web of Science ®Google Scholar
• Semenza G L. HIF-1 and mechanisms of hypoxia sensing. Current Opinion in Cell Biology 2001a; 13: 167–171
   PubMed Web of Science ®Google Scholar
• Semenza G L. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatric Research 2001b; 49: 614–617
   PubMed Web of Science ®Google Scholar
• Semenza G L. HIF-1 and tumor progression: Pathophysiology and therapeutics. Trends in Molecular Medicine 2002; 8: S62–S67
   Web of Science ®Google Scholar
• Semenza G L. Targeting HIF-1 for cancer therapy. Nature Reviews Cancer 2003; 3: 721–732
   PubMed Web of Science ®Google Scholar
• Sentjurc M, Cemazar M, Sersa G. EPR oximetry of tumors in vivo in cancer therapy. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy 2004; 60: 1379–1385
   PubMedGoogle Scholar
• Shi Q, Abbruzzese J L, Huang S, Fidler I J, Xiong Q, Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clinical Cancer Research 1999; 5: 3711–3721
   PubMed Web of Science ®Google Scholar
• Shijubo N, Uede T, Kon S, Maeda M, Segawa T, Imada A, Hirasawa M, Abe S. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. American Journal of Respiratory and Critical Care Medicine 1999; 160: 1269–1273
   PubMed Web of Science ®Google Scholar
• Shulman L N, Buswell L, Riese N, Doherty N, Loeffler J S, von Roemeling R W, Coleman C N. Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors. International Journal of Radiation Oncology, Biology, Physics 1999; 44: 349–353
   PubMed Web of Science ®Google Scholar
• Simon R, Altman D G. Statistical aspects of prognostic factor studies in oncology. British Journal of Cancer 1994; 69: 979–985
   PubMed Web of Science ®Google Scholar
• Smirnov A I, Norby S W, Clarkson R B, Walczak T, Swartz H M. Simultaneous multi-site EPR spectroscopy in vivo. Magnetic Resonance in Medicine 1993; 30: 213–220
   PubMedGoogle Scholar
• Song Y, Constantinescu A, Mason R P. Dynamic breast tumor oximetry: The development of prognostic radiology. Technology in Cancer Research and Treatment 2002; 1: 471–478
   PubMedGoogle Scholar
• Stadler P, Becker A, Feldmann H J, Hansgen G, Dunst J, Wurschmidt F, Molls M. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. International Journal of Radiation Oncology, Biology, Physics 1999; 44: 749–754
   PubMed Web of Science ®Google Scholar
• Stratford I J, Adams G E, Bremner J C, Cole S, Edwards H S, Robertson N, Wood P J. Manipulation and exploitation of the tumour environment for therapeutic benefit. International Journal of Radiation Biology 1994; 65: 85–94
   PubMed Web of Science ®Google Scholar
• Su M Y, Cheung Y C, Fruehauf J P, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen S C, Hsueh S, McLaren C E, Wan Y L. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. Journal of Magnetic Resonance Imaging 2003; 18: 467–477
   PubMed Web of Science ®Google Scholar
• Su M Y, Wang Z, Carpenter P M, Lao X, Muhler A, Nalcioglu O. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. Journal of Magnetic Resonance Imaging 1999a; 9: 177–186
   PubMedGoogle Scholar
• Su M Y, Wang Z, Nalcioglu O. Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors. Journal of Magnetic Resonance Imaging 1999b; 9: 128–137
   PubMedGoogle Scholar
• Subramanian S, Matsumoto K, Mitchell J B, Krishna M C. Radio frequency continuous-wave and time-domain EPR imaging and Overhauser-enhanced magnetic resonance imaging of small animals: instrumental developments and comparison of relative merits for functional imaging. NMR in Biomedicine 2004; 17: 263–294
   PubMed Web of Science ®Google Scholar
• Swartz H M. Potential medical (clinical) applications of EPR: overview and perspectives. In vivo EPR (ESR): Theory and applications, L J Berliner. Kluwer Academic/Plenum, New York 2003a; 600–622
   Google Scholar
• Swartz H M. The measurement of oxygen in vivo using EPR techniques. In vivo EPR (ESR): Theory and applications, L J Berliner. Kluwer Academic/Plenum, New York 2003b; 404–440
   Google Scholar
• Swartz H M, Clarkson R B. The measurement of oxygen in vivo using EPR techniques. Physics in Medicine and Biology 1998; 43: 1957–1975
   PubMedGoogle Scholar
• Swartz H M, Dunn J F. Measurements of oxygen in tissues: Overview and perspectives on methods. Oxygen transport to tissue XXIV, H M Swartz, J F Dunn. Plenum, New York 2003a; 1–12
   Google Scholar
• Swartz H M, Dunn J F. Measurements of oxygen in tissues: Overview and perspectives on methods. Advances in Experimental Medicine and Biology 2003b; 530: 1–12
   PubMedGoogle Scholar
• Swartz H M, Dunn J F. The difficulties in comparing in vivo oxygen measurements: Turning the problems into benefits. Oxygen transport to tissue XXVI, P Okunieff, J Williams, Y Chen. Plenum, New York 2005; 295–301
   Google Scholar
• Swartz H M, Khan N, Buckey J, Comi R, Gould L, Grinberg O, Hartford A, Hopf H, Hou H, Hug E, Iwasaki A, Lesniewski P, Salikhov I, Walczak T. Clinical applications of EPR: Overview and perspectives. NMR in Biomedicine 2004; 17: 335–351
   PubMed Web of Science ®Google Scholar
• Tannock I F. Experimental chemotherapy and concepts related to the cell cycle. International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine 1986; 49: 335–355
   PubMed Web of Science ®Google Scholar
• Taylor N J, Baddeley H, Goodchild K A, Powell M E, Thoumine M, Culver L A, Stirling J J, Saunders M I, Hoskin P J, Phillips H, Padhani A R, Griffiths J R. BOLD MRI of human tumor oxygenation during carbogen breathing. Journal of Magnetic Resonance Imaging 2001; 14: 156–163
   PubMedGoogle Scholar
• Terris D J. Head and neck cancer: the importance of oxygen. The Laryngoscope 2000; 110: 697–707
   PubMedGoogle Scholar
• Thomas S R. The biomedical applications of fluorine-19 NMR. Magnetic Resonance Imaging, C L Partain, R R Price, J A Patton, M V Kulkarni, A EJ James. WB Saunders, London 1988; 1536–1552
   Google Scholar
• Thomlinson R H, Gray L H. The histological structure of some human lung cancers and the possible implications for radiotherapy. British Journal of Cancer 1955; 9: 539–549
   PubMed Web of Science ®Google Scholar
• Tofts P S, Brix G, Buckley D L, Evelhoch J L, Henderson E, Knopp M V, Larsson H B, Lee T Y, Mayr N A, Parker G J, Port R E, Taylor J, Weisskoff R M. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. Journal of Magnetic Resonance Imaging 1999; 10: 223–232
   PubMed Web of Science ®Google Scholar
• Tuck A B, Arsenault D M, O'Malley F P, Hota C, Ling M C, Wilson S M, Chambers A F. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 1999; 18: 4237–4246
   PubMed Web of Science ®Google Scholar
• Turetschek K, Floyd E, Shames D M, Roberts T P, Preda A, Novikov V, Corot C, Carter W O, Brasch R C. Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology. Magnetic Resonance in Medicine 2001; 45: 880–886
   PubMedGoogle Scholar
• Turetschek K, Preda A, Floyd E, Shames D M, Novikov V, Roberts T P, Wood J M, Fu Y, Carter W O, Brasch R C. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. European Journal of Nuclear Medicine and Molecular Imaging 2003; 30: 448–455
   PubMed Web of Science ®Google Scholar
• Turetschek K, Preda A, Novikov V, Brasch R C, Weinmann H J, Wunderbaldinger P, Roberts T P. Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weights. Journal of Magnetic Resonance Imaging 2004; 20: 138–144
   PubMed Web of Science ®Google Scholar
• Urquidi V, Sloan D, Kawai K, Agarwal D, Woodman A C, Tarin D, Goodison S. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clinical Cancer Research 2002; 8: 61–74
   PubMed Web of Science ®Google Scholar
• Urtasun R C, Parliament M B, McEwan A J, Mercer J R, Mannan R H, Wiebe L I, Morin C, Chapman J D. Measurement of hypoxia in human tumours by non-invasive SPECT imaging of iodoazomycin arabinoside. British Journal of Cancer Supplement 1996; 27: S209–S212
   PubMedGoogle Scholar
• van Sluis R, Bhujwalla Z M, Raghunand N, Ballesteros P, Alvarez J, Cerdan S, Galons J P, Gillies R J. In vivo imaging of extracellular pH using 1H MRSI. Magnetic Resonance in Medicine 1999; 41: 743–750
   PubMed Web of Science ®Google Scholar
• Vaupel P, Briest S, Hockel M. Hypoxia in breast cancer: Pathogenesis, characterization and biological/therapeutic implications. Wiener Medizinische Wochenschrift 2002; 152: 334–342
   PubMedGoogle Scholar
• Vaupel P, Kelleher D K, Hockel M. Oxygen status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy. Seminars in Oncology 2001a; 28: 29–35
   PubMed Web of Science ®Google Scholar
• Vaupel P, Schlenger K, Knoop C, Hockel M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Research 1991; 51: 3316–3322
   PubMed Web of Science ®Google Scholar
• Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: Role of hypoxia and anemia. Medical Oncology 2001b; 18: 243–259
   PubMed Web of Science ®Google Scholar
• Vaupel P, Thews O, Kelleher D K, Konerding M A. O2 extraction is a key parameter determining the oxygenation status of malignant tumors and normal tissues. International Journal of Oncology 2003; 22: 795–798
   PubMedGoogle Scholar
• Vengellur A, Woods B G, Ryan H E, Johnson R S, LaPres J J. Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts. Gene Expression 2003; 11: 181–197
   PubMed Web of Science ®Google Scholar
• von Pawel J, von Roemeling R, Gatzemeier U, Boyer M, Elisson L O, Clark P, Talbot D, Rey A, Butler T W, Hirsh V, Olver I, Bergman B, Ayoub J, Richardson G, Dunlop D, Arcenas A, Vescio R, Viallet J, Treat J. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and tirapazamine in subjects with advanced previously untreated non-small-cell lung tumors. Journal of Clinical Oncology 2000; 18: 1351–1359
   PubMed Web of Science ®Google Scholar
• Vordermark D, Brown J M. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?. Strahlentherapie und Onkologie 2003; 179: 801–811
   PubMedGoogle Scholar
• Vujaskovic Z, Rosen E L, Blackwell K L, Jones E L, Brizel D M, Prosnitz L R, Samulski T V, Dewhirst M W. Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. International Journal of Hyperthermia 2003; 19: 498–506
   PubMed Web of Science ®Google Scholar
• Wachsberger P R, Burd R, Marero N, Daskalakis C, Ryan A, McCue P, Dicker A P. Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. Clinical Cancer Research 2005; 11: 835–842
   PubMed Web of Science ®Google Scholar
• Wakisaka N, Pagano J S. Epstein-Barr virus induces invasion and metastasis factors. AntiCancer Research 2003; 23: 2133–2138
   PubMedGoogle Scholar
• Weinmann H J, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiological Chemistry and Physics in Medical NMR 1984; 16: 167–172
   PubMed Web of Science ®Google Scholar
• Welsh S, Williams R, Kirkpatrick L, Paine-Murrieta G, Powis G. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Molecular Cancer Therapeutics 2004; 3: 233–244
   PubMed Web of Science ®Google Scholar
• Welsh S J, Powis G. Hypoxia inducible factor as a cancer drug target. Current Cancer Drug Targets 2003; 3: 391–405
   PubMedGoogle Scholar
• Welsh S J, Williams R R, Birmingham A, Newman D J, Kirkpatrick D L, Powis G. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. Molecular Cancer Therapeutics 2003; 2: 235–243
   PubMed Web of Science ®Google Scholar
• Wouters B G, Brown J M. Cells at intermediate oxygen levels can be more important than the hypoxic fraction in determining tumor response to fractionated radiotherapy. Radiation Research 1997; 147: 541–550
   PubMed Web of Science ®Google Scholar
• Wouters B G, Delahoussaye Y M, Evans J W, Birrell G W, Dorie M J, Wang J, MacDermed D, Chiu R K, Brown J M. Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine. Cancer Research 2001; 61: 145–152
   PubMedGoogle Scholar
• Wu Y, Denhardt D T, Rittling S R. Osteopontin is required for full expression of the transformed phenotype by the ras Oncogene. British Journal of Cancer 2000; 83: 156–163
   PubMedGoogle Scholar
• Yamada K, Inoue D, Matsumoto S, Utsumi H. In vivo measurement of redox status in streptozotocin-induced diabetic rat using targeted nitroxyl probes. Antioxidants and Redox Signaling 2004; 6: 605–611
   PubMedGoogle Scholar
• Yamada K I, Kuppusamy P, English S, Yoo J, Irie A, Subramanian S, Mitchell J B, Krishna M C. Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiologica 2002; 43: 433–440
   PubMedGoogle Scholar
• Yeatman T J, Chambers A F. Osteopontin and colon cancer progression. Clinical and Experimental Metastasis 2003; 20: 85–90
   PubMedGoogle Scholar
• Zagorevskii D, Song M, Breneman C, Yuan Y, Fuchs T, Gates K S, Greenlief C M. A mass spectrometry study of tirapazamine and its metabolites. insights into the mechanism of metabolic transformations and the characterization of reaction intermediates. Journal of the American Society for Mass Spectrometry 2003; 14: 881–892
   PubMedGoogle Scholar
• Zagzag D, Zhong H, Scalzitti J M, Laughner E, Simons J W, Semenza G L. Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression. Cancer 2000; 88: 2606–2618
   PubMed Web of Science ®Google Scholar
• Zanzonico P, O'donoghue J, Chapman J D, Schneider R, Cai S, Larson S, Wen B, Chen Y, Finn R, Ruan S, Gerweck L, Humm J, Ling C. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning. European Journal of Nuclear Medicine and Molecular Imaging 2004; 31: 117–128
   PubMed Web of Science ®Google Scholar
• Zeman E M, Brown J M, Lemmon M J, Hirst V K, Lee W W. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. International Journal of Radiation Oncology, Biology, Physics 1986; 12: 1239–1242
   PubMed Web of Science ®Google Scholar
• Zhao D, Jiang L, Hahn E W, Mason R P. Tumor physiological response to combrestatin A4 phosphate assessed by MRI. International Journal of Radiation Oncology, Biology, Physics 2005; 62: 872–880
   PubMed Web of Science ®Google Scholar
• Zhao D, Constantinescu A, Chang C H, Hahn E W, Mason R P. Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor. Radiation Research 2003a; 159: 621–631
   PubMedGoogle Scholar
• Zhao D, Constantinescu A, Hahn E W, Mason R P. Tumor oxygen dynamics with respect to growth and respiratory challenge: Investigation of the Dunning prostate R3327-HI tumor. Radiation Research 2001; 156: 510–520
   PubMed Web of Science ®Google Scholar
• Zhao D, Constantinescu A, Hahn E W, Mason R P. Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. International Journal of Radiation Oncology, Biology, Physics 2002; 53: 744–756
   PubMed Web of Science ®Google Scholar
• Zhao D, Jiang L, Mason R P. Measuring changes in tumor oxygenation. Methods in Enzymology 2004; 386: 378–418
   PubMed Web of Science ®Google Scholar
• Zhao D, Ran S, Constantinescu A, Hahn E W, Mason R P. Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia 2003b; 5: 308–318
   PubMed Web of Science ®Google Scholar
• Zhu B, Suzuki K, Goldberg H A, Rittling S R, Denhardt D T, McCulloch C A, Sodek J. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. Journal of Cell Physiology 2004; 198: 155–167
   PubMedGoogle Scholar
• Ziemer L S, Evans S M, Kachur A V, Shuman A L, Cardi C A, Jenkins W T, Karp J S, Alavi A, Dolbier W R, Jr, Koch C J. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5. European Journal of Nuclear Medicine and Molecular Imaging 2003; 30: 259–266
   PubMed Web of Science ®Google Scholar
• Ziemer L S, Koch C J, Maity A, Magarelli D P, Horan A M, Evans S M. Hypoxia and VEGF mRNA expression in human tumors. Neoplasia 2001; 3: 500–508
   PubMed Web of Science ®Google Scholar